Dr. Angel Qin
Claim this profileUniversity of Michigan Comprehensive Cancer Center
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
10 reported clinical trials
17 drugs studied
Area of expertise
1Lung Cancer
Stage IV
ALK positive
Stage III
2Non-Small Cell Lung Cancer
Stage IV
ALK positive
Stage III
Affiliated Hospitals
Clinical Trials Angel Qin is currently running
Gilteritinib
for Lung Cancer
This phase I trial is studying the safety, side effects, and best dose of gilteritinib in treating patients with stage IV ALK positive non-small cell lung cancer (NSCLC) who have progressed on other treatments. While there are many approved targeted drugs for ALK NSCLC, resistance to these drugs frequently occur. Giltertinib is a drug that is already FDA approved for the treatment of a specific type of leukemia. However, studies using ALK positive lung cancer cells demonstrate activity of gilteritinib against these resistant cells. Therefore, in this clinical trial, the investigators plan to study the effect of giltertinib in patients with ALK NSCLC.
Recruiting1 award Phase 1
LY3537982 + Immunotherapy/Chemotherapy
for Non-Small Cell Lung Cancer
This trial is testing a new drug, LY3537982, combined with standard treatments for patients with advanced lung cancer that have a specific genetic mutation. The goal is to see if this combination works better than the usual treatments alone.
Recruiting1 award Phase 314 criteria
More about Angel Qin
Clinical Trial Related1 year of experience running clinical trials · Led 10 trials as a Principal Investigator · 6 Active Clinical TrialsTreatments Angel Qin has experience with
- Pembrolizumab
- Rucaparib
- Gilteritinib
- Repotrectinib (TPX-0005)
- Durvalumab
- Ipilimumab And Nivolumab
Breakdown of trials Angel Qin has run
Lung Cancer
Non-Small Cell Lung Cancer
Cancer
Pulmonary Disease
Acute Viral Respiratory Infection
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Angel Qin specialize in?
Angel Qin focuses on Lung Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Lung Cancer has involved Stage IV patients, or patients who are ALK positive.
Is Angel Qin currently recruiting for clinical trials?
Yes, Angel Qin is currently recruiting for 6 clinical trials in Ann Arbor Michigan. If you're interested in participating, you should apply.
Are there any treatments that Angel Qin has studied deeply?
Yes, Angel Qin has studied treatments such as Pembrolizumab, Rucaparib, Gilteritinib.
What is the best way to schedule an appointment with Angel Qin?
Apply for one of the trials that Angel Qin is conducting.
What is the office address of Angel Qin?
The office of Angel Qin is located at: University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan 48109 United States. This is the address for their practice at the University of Michigan Comprehensive Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.